Answers are grounded in this paper and cite their sources.
A series of iso-structural La 5 (Si 2+ x B 1– x )(O 13– x N x ):Ce 3+ phosphors with apatite structure have been prepared. A combination of powder X-ray diffraction and neutron scattering technique was employed to explore the crystal structural evolution and the rigid nature from oxy- to oxynitride-based apatites, and some local structures were also characterized by HRTEM and 29 Si NMR data, respectively. The new La 5 (Si 2+ x B 1– x )(O 13– x N x ):Ce 3+ solid solution phosphors gave continuously controlled emission from 421 nm [La 5 Si 2 BO 13:Ce 3+, end-member ( x = 0)] to 463 nm (La 5 Si 3 O 12 N:Ce 3+, end-member ( x = 1)). Substitution of B 3+ and O 2– by Si 4+ and N 3– in La 5 (Si 2+ x B 1– x )(O 13– x N x ):Ce 3+ phosphors produced more covalency into the crystal field environment around the Ce 3+ ions inducing the red-shifted emission, further improving the thermal stability of the oxynitride-based apatite phosphors. The proposed approach from oxy- to oxynitride based iso-structural phases could significantly contribute to future research in designing complex solid solution phosphors.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: